United States · Advertising framework
Television advertising for aesthetic treatments in the United States
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Patient data require a separate HIPAA analysis
Regulator guidance
For HIPAA covered entities and business associates, marketing uses or disclosures of protected health information generally require the individual’s HIPAA authorisation, subject to the rule’s definitions and exceptions. Do not assume an ordinary mailing-list opt-in is a compliant HIPAA authorisation.
HHS identifies face-to-face communications and nominal-value promotional gifts as specific exceptions. If marketing involves qualifying third-party remuneration, the authorisation must disclose it. Assess these conditions separately from the advertising claim and any state law.
HIPAA does not cover every wellness business or health app. Its inapplicability does not establish permission under other privacy laws.
Sources: HIPAA Privacy Rule: Marketing · HHS marketing guidance; 45 CFR 164.508(a)(3)
California: verify the licence behind a telehealth offer
Regulator guidance
Applies when: California physician telehealth route; other states and statutory exceptions require separate analysis.
For the California route described by the Medical Board, the physician needs a current California licence even when residing elsewhere, and the standard of care is the same as for in-person medicine. A nationwide website or remote consultation technology does not establish permission to treat patients in every state. Identify the patient location and applicable licence before advertising availability.
Channel rules
Review implied claims as well as literal wording
Regulator guidance
FTC guidance assesses the overall impression of health advertising. Hold appropriate scientific evidence before publication; an honest testimonial does not substitute for evidence of the advertised result. Treat imagery and omitted qualifications as part of that assessment.
Washington health data may be regulated outside HIPAA
Regulator guidance
Applies when: Processing within the scope of Washington’s My Health My Data Act.
Where Washington’s My Health My Data Act applies, collection generally needs purpose-specific consent unless necessary for a requested product or service; sharing requires a distinct consent unless the necessary-service exception applies. Review applicability and exemptions by data and activity, rather than assuming HIPAA status clears advertising tracking. Regulated entities must prominently link a separate consumer health data privacy policy from the homepage.
Sources: Washington consumer-health-data collection and sharing; My Health My Data Act — scope and FAQ
Review the broadcast execution
Editorial recommendation
Confirm product eligibility for public broadcast and the applicable broadcaster code and clearance process. Review warning timing, speech and image together; internet-video approval does not automatically cover television.
State expected results instead of relying on a generic disclaimer
Regulator guidance
FTC guidance says an honest endorsement can still mislead. When a testimonial communicates exceptional results, a generic results-not-typical disclaimer does not cure the impression; disclose the results consumers can generally expect and substantiate the underlying claim.
Sources: FTC Health Products Compliance Guidance · FTC Health Products Compliance Guidance, consumer testimonials and expert endorsements
Campaign workflow
Aesthetic Medicine & Cosmetic Procedures: prepare the review
Editorial recommendation
Separate the procedure, clinic, device, cosmetic and prescription medicine in the offer. Check restrictions on injectables and other products even when the headline advertises a consultation. Review realistic outcomes, risks, patient images and time-limited offers.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Separate the procedure, clinic, device, cosmetic and prescription medicine in the offer.
- Check restrictions on injectables and other products even when the headline advertises a consultation.
- Review realistic outcomes, risks, patient images and time-limited offers.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- California physician telehealth and Washington consumer-health-data requirements are now documented as scoped examples. Other state medical/dental/pharmacy rules, corporate practice, fee splitting, referral arrangements and state telemarketing laws remain to be assessed for the actual provider and patient location.
- FDA television/radio-format standards and a scoped Washington health-data rule are documented. Exact TCPA revocation implementation dates and post-litigation consent text were not fully verified from accessible primary documents; final SMS clearance remains open. Platform, broadcaster and other state rules depend on the actual execution.
Research scope, introduction and dates
An aesthetic campaign in television campaigns in the United States can advertise a clinic while also implying claims about a procedure, device or prescription medicine. Separate those elements first, then review outcome images, risks and commercial pressure.
For television, assess both the creative and the broadcaster's classification of the placement. Presenter choice, voiceover, warning panels and cut-down versions need to work within the same execution; sponsorship and product placement have their own conditions.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Federal advertising baseline; state professional, pharmacy and privacy rules require a separate review. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- HIPAA Privacy Rule: Marketing
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- FTC Health Products Compliance Guidance
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- California physician telehealth requirements
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- Washington consumer-health-data collection and sharing
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- My Health My Data Act — scope and FAQ
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in United States
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in United States.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.
